Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLetter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.AuthorsJiang, J.‐F.; Sun, J.; Shi, J.; Liu, X.AbstractLinked Content This article is linked to Gounder et al papers. To view these articles visit https://doi.org/10.1111/apt.14026 and https://doi.org/10.1111/apt.13621.SubjectsCANCER risk factors; LIVER cancer; HEPATITIS B -- Immunological aspects; CELL surface antigensPublicationAlimentary Pharmacology & Therapeutics, 2017, Vol 45, Issue 9, p1286ISSN0269-2813Publication typeArticleDOI10.1111/apt.13983